BVI Medical Raises $1 Billion to Fuel Global Growth

BVI Medical has completed a $1 billion strategic capital raise in partnership with asset management firm TPG. According to BVI, the investment, which fully refinances BVI’s existing debt and adds new equity from both TPG and new investors, aims to strengthen the company’s financial position as it looks to accelerate product innovation and expand its global footprint.

Recently, BVI expanded its IOL manufacturing in Europe to meet growing global demand, introduced new product lines such as Serenity and Serenity Toric premium monofocal IOLs, and strengthened its market position through strategic acquisitions.

“This investment marks a pivotal moment for BVI as we scale our capabilities to meet the rising demand for advanced ophthalmic solutions,” Shervin Korangy, President and CEO said in a company news release. “We are redefining the future of eye surgery and changing the competitive landscape by driving the launch of breakthrough technologies that will empower surgeons worldwide.”